Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells

J Biol Chem. 2021 Jan-Jun:296:100319. doi: 10.1016/j.jbc.2021.100319. Epub 2021 Jan 22.

Abstract

Upregulation of the neuropeptide neurotensin (NTS) in a subgroup of lung cancers has been linked to poor prognosis. However, the regulatory pathway centered on NTS in lung cancer remains unclear. Here we identified the NTS-specific enhancer in lung adenocarcinoma cells. The AF4/FMR2 (AFF) family protein AFF1 occupies the NTS enhancer and inhibits NTS transcription. Clustering analysis of lung adenocarcinoma gene expression data demonstrated that NTS expression is highly positively correlated with the expression of the oncogenic factor CPS1. Detailed analyses demonstrated that the IL6 pathway antagonizes NTS in regulating CPS1. Thus, our analyses revealed a novel NTS-centered regulatory axis, consisting of AFF1 as a master transcription suppressor and IL6 as an antagonist in lung adenocarcinoma cells.

Keywords: AFF1; enhancer; lung adenocarcinoma; neurotensin; transcription regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Adenocarcinoma of Lung / genetics*
  • Adenocarcinoma of Lung / pathology
  • Carbamoyl-Phosphate Synthase (Ammonia) / genetics*
  • Cell Proliferation / genetics
  • DNA-Binding Proteins / genetics*
  • Enhancer Elements, Genetic / genetics
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Interleukin-6 / genetics*
  • Male
  • Neurotensin / genetics*
  • Prognosis
  • Signal Transduction / genetics
  • Transcriptional Elongation Factors / genetics*

Substances

  • DNA-Binding Proteins
  • IL6 protein, human
  • Interleukin-6
  • Transcriptional Elongation Factors
  • AFF1 protein, human
  • Neurotensin
  • CPS1 protein, human
  • Carbamoyl-Phosphate Synthase (Ammonia)